II
DXCM icon

IFM Investors’s DexCom DXCM Stock Holding History

IFM Investors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29M Buy
93,394
+8,771
+10% +$584K 0.04% 359
2026
Q1 		$5.31M Buy
84,623
+2,406
+3% +$168K 0.04% 356
2025
Q4 		$5.46M Hold
82,217
– – 0.05% 340
2025
Q3 		$5.52M Buy
82,217
+405
+0.5% +$32K 0.05% 323
2025
Q2 		$7.14M Buy
81,812
+7,619
+10% +$597K 0.07% 267
2025
Q1 		$5.07M Hold
74,193
– – 0.05% 317
2024
Q4 		$5.77M Sell
74,193
-6,601
-8% -$489K 0.06% 309
2024
Q3 		$5.42M Buy
80,794
+415
+0.5% +$34.1K 0.05% 340
2024
Q2 		$9.11M Buy
80,379
+696
+0.9% +$88K 0.09% 206
2024
Q1 		$11.1M Sell
79,683
-901
-1% -$113K 0.12% 168
2023
Q4 		$10M Sell
80,584
-774
-1% -$79.1K 0.12% 171
2023
Q3 		$7.59M Buy
81,358
+2,943
+4% +$332K 0.1% 208
2023
Q2 		$10.1M Buy
78,415
+5,115
+7% +$619K 0.13% 149
2023
Q1 		$8.52M Buy
73,300
+1,086
+2% +$122K 0.13% 163
2022
Q4 		$8.18M Buy
72,214
+4,588
+7% +$504K 0.14% 159
2022
Q3 		$5.45M Buy
67,626
+2,142
+3% +$181K 0.1% 223
2022
Q2 		$4.88M Buy
65,484
+2,056
+3% +$188K 0.09% 246
2022
Q1 		$8.11M Buy
63,428
+13,024
+26% +$1.42M 0.13% 165
2021
Q4 		$6.77M Sell
50,404
-384
-0.8% -$55.2K 0.12% 151
2021
Q3 		$6.94M Buy
50,788
+372
+0.7% +$46.9K 0.14% 133
2021
Q2 		$5.38M Buy
50,416
+8,280
+20% +$795K 0.11% 185
2021
Q1 		$3.79M Buy
42,136
+6,032
+17% +$566K 0.1% 209
2020
Q4 		$3.34M Buy
36,104
+5,760
+19% +$514K 0.11% 189
2020
Q3 		$3.13M Buy
30,344
+3,324
+12% +$347K 0.13% 146
2020
Q2 		$2.74M Sell
27,020
-10,536
-28% -$942K 0.14% 144
2020
Q1 		$2.61M Sell
37,556
-1,464
-4% -$91.1K 0.12% 169
2019
Q4 		$2.13M Buy
39,020
+2,080
+6% +$98.7K 0.08% 275
2019
Q3 		$1.38M Buy
36,940
+11,716
+46% +$455K 0.05% 374
2019
Q2 		$945K Buy
25,224
+4,840
+24% +$152K 0.05% 369
2019
Q1 		$607K Hold
20,384
– – 0.04% 446
2018
Q4 		$611K Buy
+20,384
New +$647K 0.05% 399

Other funds holding DXCM

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

IFM Investors's DXCM Position: Q2 2026 in Review

IFM Investors increased its DexCom (DXCM) stake by 10% in Q2 2026, buying an estimated $584K and bringing the position to 93,394 shares worth $6.29M. The position accounts for 0.04% of the portfolio, ranked #359.

IFM Investors first reported a position in DXCM in Q4 2018 and has held it in 31 quarters since. The position peaked at $11.1M in Q1 2024. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • IFM Investors held 93,394 shares of DexCom worth $6.29M as of Q2 2026.
  • IFM Investors bought 8,771 DexCom shares in Q2 2026, an estimated $584K.
  • DexCom made up 0.04% of IFM Investors's portfolio in Q2 2026, its #359 holding.
  • IFM Investors first reported a position in DexCom in Q4 2018 and has held it in 31 quarters since.
  • IFM Investors's DexCom position peaked at $11.1M in Q1 2024.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.